The science behind AquaLink

A softly lit laboratory bench with glassware and the AquaLink tub

Your body’s ability to maintain health depends on precise communication between cells. When this communication becomes disrupted, it can contribute to chronic low-grade inflammation and reduced resilience.

This page explains the background science, the hydration-shell technology, and AquaLink’s proposed mechanisms, and keeps the three clearly separate.

Foundation

Cellular communication · Hydration shell

Proposed mechanism

Four steps · Three mechanisms

Galectin-3

Lattice · Inflammation · Fibrosis · Independent research

Relevance

What this means for AquaLink

Illustration of a branching molecular network: blue and gold spheres joined by slender bonds, suspended in water

Cellular communication

Galectin-3 is a β-galactoside-binding protein that plays a central role in inflammation, immune signaling, and tissue fibrosis. It acts as a molecular organizer on cell surfaces and as an amplifier of inflammatory and fibrotic pathways when dysregulated.

The Galectin-3 lattice acts like temporary scaffolding on the cell surface. It holds certain receptors in place, slows their removal, and organizes them so signaling becomes stronger or lasts longer.

Background science. This describes how Galectin-3 behaves in the body; it is not a description of what AquaLink does.

Understanding Galectin-3 helps explain why certain polysaccharides (such as arabinogalactan in AquaLink) are of interest for supporting balanced cellular communication and a healthy inflammatory response.

A protective shell, built in water

AquaLink is a functional beverage powered by a patented, thermally reversible hydrogen-bonded hydration shell formed in electrolyzed alkaline water around functional polysaccharides.

This technology helps protect these polysaccharides during digestion and supports their delivery, contributing to clearer cellular signaling and a more balanced inflammatory response.

Illustration of gold ring-shaped molecules held inside spheres of water, beside a coiled blue strand

The water environment

Electrolyzed alkaline water, in which the hydration shell forms.

The shell

A thermally reversible, hydrogen-bonded structure formed around the polysaccharides.

The functional polysaccharides

Including arabinogalactan, which the shell helps protect during digestion and supports in delivery.

How the proposed mechanism works

Four key steps:

Illustration of the polysaccharide forming a protective shell around water molecules

Protect

Protects key polysaccharides through the digestive tract

Illustration of the hydration shell moving through a cell membrane channel

Transport

Enhances cellular uptake via aquaporin water channels

Illustration of water being released inside the cell

Deliver

Delivers polysaccharides where they can interact with the glycan lattice

Illustration of a hydrated cell with restored structure

Support

Supports healthy glycan lattice organization and galectin receptor activity

Three interconnected mechanisms

AquaLink’s technology is designed to support healthier cellular signaling through three interconnected mechanisms:

Wide illustration of molecules travelling through water, passing a coiled channel and joining a lattice of linked spheres

Protection during digestion

The hydration shell creates a protective barrier around the polysaccharides.

Enhanced cellular uptake

Structured water with reduced surface tension supports more efficient movement through aquaporin channels.

Modulation of the glycan lattice

The branched polysaccharides help support healthier galectin receptor activity.

Galectin-3 lattice signaling

Galectin-3 forms dynamic lattices on the surface of cells that control how certain receptors send signals.

How the lattice forms

Galectin-3 binds to sugar structures (glycans) on cell-surface proteins.

Through its N-terminal domain it oligomerizes (often forming pentamers or larger structures).

These oligomers cross-link multiple glycoproteins, creating a lattice-like network on the membrane.

How the lattice affects signaling

Slows receptor internalization

Receptors stay on the surface longer and continue signaling.

Organizes and clusters receptors

Brings certain receptors closer together or keeps them apart.

Stabilizes growth factor and cytokine receptors

Especially TGF-β receptors and integrins.

Raises the threshold for some immune signals

Can limit excessive T-cell receptor clustering.

Supports chronic inflammation and fibrosis

By keeping pro-inflammatory and pro-fibrotic receptors active longer.

Galectin-3 and inflammation

Galectin-3 contributes to both the initiation and the persistence of inflammation.

MechanismWhat happens
Macrophage recruitment & activationAttracts and activates macrophages at sites of injury or stress.
NLRP3 inflammasome activationIncreases release of pro-inflammatory cytokines IL-1β and IL-18.
TLR4 signalingTriggers the NF-κB pathway and further inflammatory gene expression.
Lattice formationStabilizes receptors and prolongs inflammatory and fibrotic signaling.
Cytokine & chemokine interactionsModulates immune cell migration and can amplify or fine-tune the response.

Key point: in acute injury Galectin-3 helps the body respond. When inflammation becomes chronic, elevated Galectin-3 sustains the response and drives tissue remodeling.

Galectin-3 and fibrosis

Galectin-3 is a major driver of tissue fibrosis (scarring). It sits at the crossroads of chronic inflammation and excessive extracellular matrix production.

Main pro-fibrotic actions

Myofibroblast activation

Required for fibroblasts to become matrix-secreting myofibroblasts.

Enhancement of TGF-β signaling

Helps activate TGF-β1 and stabilizes its receptors.

Macrophage polarization

Promotes a pro-fibrotic macrophage phenotype.

Inflammation-to-fibrosis transition

Pushes unresolved inflammation toward scarring.

Direct matrix production

Stimulates collagen and extracellular matrix production.

Galectin-3 drives fibrosis in liver, lung, heart, and kidney. Reducing its activity significantly limits scarring in experimental models.

Independent research

An independent clinical perspective

Galectin-3 has become the subject of growing clinical interest. The overview below is written by a practising physician and is summarised here so you can read the underlying discussion in full, at the source.

Source

Dr. Jill C. Carnahan

MD, ABIHM, IFMCP

Published 17 February 2026

jillcarnahan.com

READ THE FULL ARTICLE

This is an independent article by Dr. Jill C. Carnahan. It is not affiliated with, commissioned by, or about AquaLink. It does not mention AquaLink, arabinogalactan or hydration-shell technology, and nothing in it describes what AquaLink does. It is provided as background reading on Galectin-3 only.

Galectin-3: The Hidden Driver of Inflammation, Fibrosis, and Chronic Disease

Carnahan describes Galectin-3 as a beta-galactoside-binding lectin found throughout the body, where it binds to sugar molecules on cell surfaces. She writes that it is protective under normal conditions, but that chronic elevation turns it into a driver of disease rather than a defence against it.

The article connects sustained Galectin-3 activity to pro-inflammatory signalling, and to fibrosis, describing how it can activate fibroblasts to produce excess collagen and scar tissue across cardiac, liver, kidney and lung tissue.

Her central argument is that Galectin-3 is both measurable and modifiable. She argues it is among the most important biomarkers not routinely measured, and reviews the dietary, nutritional and lifestyle research around it.

What the article covers

What Galectin-3 is, and how it behaves on the cell surface

Its role in inflammatory signalling

Fibrosis in cardiac, liver, kidney and lung tissue

Blood testing, and who she suggests testing

Diet, nutrition, exercise, sleep and stress research

Relevance to AquaLink

Arabinogalactan, a key polysaccharide in AquaLink, contains galactose structures that can bind to the carbohydrate-recognition domain of Galectin-3.

By interacting with these binding sites (particularly in the gut), arabinogalactan may help modulate lattice formation and related inflammatory signaling. The hydration shell technology is designed to protect and support delivery of these polysaccharides.

Close-up render of an intact glycan lattice on the cell surface

Important distinction

AquaLink supports a healthy inflammatory response and cellular communication. It is not a treatment for any disease.

Questions about the science

A short selection from the FAQ.

VIEW ALL FAQS

What is the hydration shell?

It is a thermally reversible, hydrogen-bonded structure formed around the polysaccharides in electrolyzed alkaline water. This shell helps protect the compounds during digestion and supports their delivery.

How is AquaLink different from regular alkaline water?

Regular alkaline water provides pH-adjusted water. AquaLink adds functional polysaccharides protected by a patented hydration shell, designed to support cellular communication and a more balanced inflammatory response.

Does AquaLink treat Dercum’s disease?

No. AquaLink is not a treatment, cure, or therapy for Dercum’s disease (adiposis dolorosa) or any medical condition. It is a supportive daily beverage designed to promote hydration and balanced inflammatory signaling.

Are you open to partnerships or research discussions?

Yes. AquaLink is built on a platform technology. We welcome conversations with practitioners, researchers, and organizations interested in supportive approaches for people living with complex inflammatory conditions.

Support Your Daily Routine

Learn more about AquaLink’s science and how it is designed to support hydration and healthy cellular function.